BBI-355
Product Specifications
CAS Number
2871056-82-3
SKU
C02004-5mg
Target
Chk
Applications
Cell Cycle
Additionnal Information
BBI-355 is an oral, potent, and selective small molecule inhibitor of CHK1 with an IC50 of 0.3 nM. It demonstrates significant anti-tumor activity as a single agent and in combination with targeted therapies in multiple ecDNA+ oncogene amplified tumor models.
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS2038516-01 0.1 mL
APC/CY7-Linked Monoclonal Antibody to Tumor Necrosis Factor Alpha (TNFa)
Ask
View Details 
MBS2038516-02 0.2 mL
APC/CY7-Linked Monoclonal Antibody to Tumor Necrosis Factor Alpha (TNFa)
Ask
View Details 
MBS2038516-03 0.5 mL
APC/CY7-Linked Monoclonal Antibody to Tumor Necrosis Factor Alpha (TNFa)
Ask
View Details MBS2038516-04 1 mL
APC/CY7-Linked Monoclonal Antibody to Tumor Necrosis Factor Alpha (TNFa)
Ask
View Details MBS2038516-05 5 mL
APC/CY7-Linked Monoclonal Antibody to Tumor Necrosis Factor Alpha (TNFa)
Ask
View Details MBS2038516-06 5x 5 mL
APC/CY7-Linked Monoclonal Antibody to Tumor Necrosis Factor Alpha (TNFa)
Ask
View Details